EF-CAB13 inhibitors are a class of chemical compounds that target and modulate the activity of EF-CAB13, a calcium-binding protein that is part of the broader family of EF-hand calcium-binding proteins. These proteins play a crucial role in the regulation of intracellular calcium levels, which are pivotal for a variety of cellular processes including signal transduction, muscle contraction, and enzyme activity. EF-CAB13, in particular, is involved in sensing and responding to changes in calcium concentrations within cells, functioning as a mediator that transduces calcium signals into specific cellular responses. By binding to calcium ions, EF-CAB13 undergoes conformational changes that allow it to interact with various target proteins, thereby influencing processes such as gene expression, cell motility, and cell cycle progression.
Inhibitors of EF-CAB13 typically function by interfering with the protein's ability to bind calcium or by disrupting its interaction with target proteins. These inhibitors may bind directly to the calcium-binding sites on EF-CAB13, preventing calcium from binding and thus blocking the conformational changes necessary for its activity. Alternatively, they might induce conformational changes in EF-CAB13 that inhibit its ability to interact with downstream targets, thereby modulating the cellular pathways regulated by calcium signaling. By inhibiting EF-CAB13, researchers can study the specific roles this protein plays in cellular calcium homeostasis and the broader implications of calcium signaling in various biological processes. EF-CAB13 inhibitors are valuable tools in the exploration of calcium-dependent signaling networks, helping to elucidate the complex mechanisms that regulate cellular functions in response to fluctuating calcium levels. Through these studies, scientists can gain deeper insights into the molecular dynamics of calcium binding and the intricate control of cellular activities by calcium signaling proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can disrupt signal transduction pathways involving phosphorylation, which may be required for EF-CAB13 activation or stabilization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can impede the PI3K/Akt pathway, potentially affecting EF-CAB13 if it is regulated by this pathway for membrane localization or function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that can block the MAPK/ERK pathway, potentially altering EF-CAB13 function if it is modulated by ERK-mediated phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can impede cellular responses to stress or cytokines, potentially influencing EF-CAB13 if it is involved in these responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect cell growth and proliferation pathways, potentially affecting EF-CAB13 if it is involved in mTOR signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that can alter multiple signaling pathways, potentially affecting EF-CAB13 activity or expression if it is PI3K-dependent. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which can affect apoptosis and cell differentiation pathways, potentially influencing EF-CAB13 if it is modulated by JNK signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
A Src family kinase inhibitor that can affect cell adhesion, growth, and differentiation, potentially altering EF-CAB13 if it interacts with Src kinases. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
An Aurora kinase inhibitor that can disrupt mitosis and cell division, potentially influencing EF-CAB13 if it plays a role in cell cycle regulation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect protein degradation pathways, potentially stabilizing EF-CAB13 if it is normally targeted for degradation. | ||||||